Biomarker & Intervention Discovery

Fibromyalgia

Pharmacologically actionable gene targets, therapeutic agents ranked by evidence tier, and active clinical trials.

US DALYs4.08MWHO GHE 2021 · all ages
Global DALYs45.69MWHO GHE 2021 · worldwide
US mortality12.5K deaths/yrWHO GHE 2021
Global mortality110.0K deaths/yrWHO GHE 2021 · worldwide
NIH funding$15MFY2025 · RCDC estimate
Funding levelSeverely Underfunded
Spontaneous remissionPartial spontaneous improvement in ~25-30% over 5 years; complete resolution without treatment rare; chronic…
Best-intervention remissionMultimodal approach (aerobic exercise + CBT + sleep optimisation): most effective combination — 50-60% significant…
Gap sizeLarge — pharmacotherapy is modestly effective; exercise is the most effective single intervention but chronically…
Primary barrierframing/practice
Full remission profile →

Remission & chronicity

Spontaneous remission
Partial spontaneous improvement in ~25-30% over 5 years; complete resolution without treatment rare; chronic fluctuating course in majority; central sensitisation often persists
Best-intervention remission
Multimodal approach (aerobic exercise + CBT + sleep optimisation): most effective combination — 50-60% significant improvement; duloxetine: 50% pain response in 43% vs 29% placebo; milnacipran: similar; pregabalin: 50% pain response 38-50%; low-dose naltrexone (LDN): 30% improvement in open-label studies
Gap size
Large — pharmacotherapy is modestly effective; exercise is the most effective single intervention but chronically underused as 'too painful'; disease is often dismissed
Primary barrier
framing/practice
Fibromyalgia was dismissed as non-organic by mainstream medicine for decades; this has resulted in: delayed diagnosis (mean 5 years), inappropriate investigations, ineffective treatments (opioids in particular), and under-referral to physiotherapy and psychological therapies; the 2010 ACR criteria removed tender point requirement and improved diagnosis
Biomarker Targets & Therapeutic Agents

Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: ● Clinical > ● Mechanistic > ● Correlative.

GRIN1 183GRIN2B 238SCN9A 271SLC6A2 269SLC6A4 224TRPV1 160
Therapeutic Agent Effect Direction Evidence Tier Potency Source
COMPOUND 53 [PMID: 33038794] activates Mechanistic
PAREGORIC ? unclear Mechanistic
STING AGONIST 2 activates Mechanistic
LATREPIRDINE ? unclear Mechanistic
CNS-5161 inhibits Mechanistic
MEMANTINE HYDROCHLORIDE ~ modulates Mechanistic
LANICEMINE inhibits Mechanistic
ULEVOSTINAG activates Mechanistic
ELIPRODIL ? unclear Mechanistic
NBQX ? unclear Mechanistic
RAPASTINEL ? unclear Mechanistic
DEXANABINOL ? unclear Mechanistic
NEBOGLAMINE ~ modulates Mechanistic
HALOPERIDOL DECANOATE ? unclear Mechanistic
ORPHENADRINE ? unclear Mechanistic
GW468816 inhibits Mechanistic
ACAMPROSATE CALCIUM inhibits Mechanistic
AMANTADINE HYDROCHLORIDE inhibits Mechanistic
H-151 inhibits Mechanistic
D-SERINE ? unclear Mechanistic
AZD8108 inhibits Mechanistic
KETAMINE HYDROCHLORIDE ~ modulates Mechanistic
DELUCEMINE inhibits Mechanistic
EVT-101 inhibits Mechanistic
MSA-2 activates Mechanistic
ESKETAMINE HYDROCHLORIDE ? unclear Mechanistic
2'3'-CGAMP activates Mechanistic
COMPOUND 40 [PMID: 33470814] activates Mechanistic
PHILANTHOTOXIN 343 ? unclear Mechanistic
FELBAMATE inhibits Mechanistic
INDANTADOL inhibits Mechanistic
STING AGONIST 3 activates Mechanistic
ORPHENADRINE HYDROCHLORIDE inhibits Mechanistic
CYCLOSERINE ? unclear Mechanistic
RADIPRODIL inhibits Mechanistic
PERZINFOTEL inhibits Mechanistic
ESKETAMINE ~ modulates Mechanistic
ADU-S100 activates Mechanistic
RALFINAMIDE inhibits Mechanistic
SNX281 activates Mechanistic

Showing top 40 of 183 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
DIMIRACETAM ? unclear Mechanistic
KETAMINE HYDROCHLORIDE inhibits Mechanistic
PERZINFOTEL inhibits Mechanistic
[3H]CGP39653 inhibits Mechanistic
PHENCYCLIDINE inhibits Mechanistic
DEXANABINOL ? unclear Mechanistic
RAPASTINEL activates Mechanistic
DELUCEMINE inhibits Mechanistic
AMANTADINE HYDROCHLORIDE inhibits Mechanistic
RISLENEMDAZ inhibits Mechanistic
ORPHENADRINE CITRATE inhibits Mechanistic
ELIPRODIL ? unclear Mechanistic 13.0 nM (Ki)
INDANTADOL ? unclear Mechanistic
SEVOFLURANE ? unclear Mechanistic
SAGE-718 ~ modulates Mechanistic
L689560 inhibits Mechanistic
ONFASPRODIL ~ modulates Mechanistic
HOMOQUINOLINIC ACID activates Mechanistic
NEBOGLAMINE ~ modulates Mechanistic
DIZOCILPINE inhibits Mechanistic
LY233053 inhibits Mechanistic
GLYCINE activates Mechanistic
ESKETAMINE ~ modulates Mechanistic
[3H]CGP61594 inhibits Mechanistic
ORPHENADRINE HYDROCHLORIDE inhibits Mechanistic
[3H]MDL105519 inhibits Mechanistic
RADIPRODIL ? unclear Mechanistic
NBQX ? unclear Mechanistic
SEMAPIMOD inhibits Mechanistic
SELFOTEL inhibits Mechanistic
SERINE, D- activates Mechanistic
COMPOUND 18C [PMID: 25901531] inhibits Mechanistic
AZD8108 inhibits Mechanistic
[3H]L689560 inhibits Mechanistic
TRAXOPRODIL inhibits Mechanistic 74.0 nM (IC50)
HALOPERIDOL DECANOATE ? unclear Mechanistic
N1-DANSYL-SPERMINE inhibits Mechanistic
[3H]D-ASPARTIC ACID activates Mechanistic
NERAMEXANE ? unclear Mechanistic
NVP-AAM077 inhibits Mechanistic

Showing top 40 of 238 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
MERETHOXYLLINE PROCAINE inhibits Mechanistic
ETIDOCAINE HYDROCHLORIDE inhibits Mechanistic
FOSPHENYTOIN inhibits Mechanistic
VERATRIDINE activates Mechanistic
ORPHENADRINE CITRATE inhibits Mechanistic
PHENACEMIDE inhibits Mechanistic
LACOSAMIDE inhibits Mechanistic
VIXOTRIGINE inhibits Mechanistic
DSP-2230 inhibits Mechanistic
SAXITOXIN inhibits Mechanistic
ESLICARBAZEPINE ACETATE inhibits Mechanistic
SAFINAMIDE ? unclear Mechanistic
LIDOCAINE inhibits Mechanistic
RILUZOLE inhibits Mechanistic
ROPIVACAINE HYDROCHLORIDE inhibits Mechanistic
FUNAPIDE inhibits Mechanistic
DYCLONINE HYDROCHLORIDE inhibits Mechanistic
EVENAMIDE inhibits Mechanistic
PROPOFOL ? unclear Mechanistic
AM-6120 inhibits Mechanistic
RG7893 inhibits Mechanistic
RG6029 inhibits Mechanistic
QUINIDINE SULFATE inhibits Mechanistic
ZONISAMIDE inhibits Mechanistic
NERISPIRDINE inhibits Mechanistic
RALFINAMIDE inhibits Mechanistic
DS-1971A inhibits Mechanistic
HEXYLCAINE HYDROCHLORIDE inhibits Mechanistic
MEPIVACAINE HYDROCHLORIDE inhibits Mechanistic
PROCAINAMIDE HYDROCHLORIDE inhibits Mechanistic
PROPAFENONE HYDROCHLORIDE inhibits Mechanistic
LIDOCAINE HYDROCHLORIDE inhibits Mechanistic
QUINIDINE GLUCONATE inhibits Mechanistic
PRILOCAINE inhibits Mechanistic
ETHOTOIN inhibits Mechanistic
PF-05089771 inhibits Mechanistic
DICHLOROBENZYL ALCOHOL inhibits Mechanistic
RANOLAZINE ? unclear Mechanistic
PRILOCAINE HYDROCHLORIDE inhibits Mechanistic
ORPHENADRINE HYDROCHLORIDE inhibits Mechanistic

Showing top 40 of 271 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
TESOFENSINE inhibits Mechanistic
PHENMETRAZINE ? unclear Mechanistic
VENLAFAXINE ? unclear Mechanistic 1060.0 nM (Kd)
SIBUTRAMINE HYDROCHLORIDE inhibits Mechanistic
DEXMETHYLPHENIDATE inhibits Mechanistic
TRIMIPRAMINE ? unclear Mechanistic
CLOMIPRAMINE ? unclear Mechanistic
GUANADREL SULFATE ? unclear Mechanistic
TAPENTADOL HYDROCHLORIDE inhibits Mechanistic
LISDEXAMFETAMINE DIMESYLATE ? unclear Mechanistic
PROTRIPTYLINE ? unclear Mechanistic
DESVENLAFAXINE SUCCINATE inhibits Mechanistic
ATOMOXETINE HYDROCHLORIDE inhibits Mechanistic
IOBENGUANE I-123 ? unclear Mechanistic
SURONACRINE MALEATE ? unclear Mechanistic
REBOXETINE inhibits Mechanistic 1.1 nM (Ki)
BICIFADINE inhibits Mechanistic
DOXEPIN HYDROCHLORIDE inhibits Mechanistic
LIAFENSINE inhibits Mechanistic
ORPHENADRINE HYDROCHLORIDE inhibits Mechanistic
DULOXETINE HYDROCHLORIDE inhibits Mechanistic
DASOTRALINE inhibits Mechanistic
DESIPRAMINE HYDROCHLORIDE inhibits Mechanistic
METHYLPHENIDATE HYDROCHLORIDE inhibits Mechanistic
AMITIFADINE inhibits Mechanistic
NEFAZODONE ? unclear Mechanistic 360.0 nM (Kd)
AMITIFADINE HYDROCHLORIDE ? unclear Mechanistic
DEXTROAMPHETAMINE SULFATE ? unclear Mechanistic
TYROSINE HYDROXYLASE INHIBITOR ? unclear Mechanistic
NORTRIPTYLINE ? unclear Mechanistic 6.3 nM (Ki)
MAPROTILINE HYDROCHLORIDE inhibits Mechanistic
ST. JOHN'S WORT ? unclear Mechanistic
DEXTROAMPHETAMINE SACCHARATE ? unclear Mechanistic
AMOXAPINE inhibits Mechanistic
PHENDIMETRAZINE inhibits Mechanistic
PHENYLPROPANOLAMINE HYDROCHLORIDE ? unclear Mechanistic
BUPROPION HYDROCHLORIDE inhibits Mechanistic
BETHANIDINE ? unclear Mechanistic
TRAMADOL ? unclear Mechanistic
MILNACIPRAN ? unclear Mechanistic

Showing top 40 of 269 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
CENTANAFADINE inhibits Mechanistic
METHAMPHETAMINE inhibits Mechanistic
VENLAFAXINE HYDROCHLORIDE inhibits Mechanistic
LUMATEPERONE inhibits Mechanistic
TIANEPTINE ? unclear Mechanistic
IMIPRAMINE HYDROCHLORIDE inhibits Mechanistic
ONDANSETRON HYDROCHLORIDE ? unclear Mechanistic
PEGINTERFERON ALFA-2B ? unclear Mechanistic
DEXFENFLURAMINE ? unclear Mechanistic
BUPROPION HYDROCHLORIDE ? unclear Mechanistic
CITALOPRAM inhibits Mechanistic 1.6 nM (Ki)
TRIMIPRAMINE ? unclear Mechanistic
VENLAFAXINE ? unclear Mechanistic 8.9 nM (Kd)
DISULFIRAM ? unclear Mechanistic
CHLORPHENTERMINE HYDROCHLORIDE ? unclear Mechanistic
PROTRIPTYLINE ? unclear Mechanistic
MILNACIPRAN HYDROCHLORIDE inhibits Mechanistic
CLOMIPRAMINE ? unclear Mechanistic 70.0 nM (IC50)
NORTRIPTYLINE ? unclear Mechanistic
DAPOXETINE inhibits Mechanistic
AMITRIPTYLINE HYDROCHLORIDE inhibits Mechanistic
TEDATIOXETINE inhibits Mechanistic
TRAZODONE inhibits Mechanistic
SERTRALINE HYDROCHLORIDE inhibits Mechanistic
EVODIAMINE ? unclear Mechanistic
PSEUDOEPHEDRINE ? unclear Mechanistic
FLUOXETINE HYDROCHLORIDE inhibits Mechanistic
SIBUTRAMINE ? unclear Mechanistic
TRAMADOL ? unclear Mechanistic
VORTIOXETINE HYDROBROMIDE inhibits Mechanistic
BL-1021 ? unclear Mechanistic
DOXEPIN HYDROCHLORIDE ? unclear Mechanistic
DOTHIEPIN inhibits Mechanistic
DEXTROMETHORPHAN POLISTIREX ? unclear Mechanistic
DESIPRAMINE ? unclear Mechanistic
PHENTERMINE RESIN ? unclear Mechanistic
NORTRIPTYLINE HYDROCHLORIDE inhibits Mechanistic
MONOAMINE OXIDASE INHIBITOR ? unclear Mechanistic
MILNACIPRAN ? unclear Mechanistic
RIBAVIRIN ? unclear Mechanistic

Showing top 40 of 224 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
STREPTOZOCIN ? unclear Mechanistic
BENZYL ISOTHIOCYANATE ? unclear Mechanistic
ACETAMINOPHEN activates Mechanistic
POLYGODIAL ? unclear Mechanistic
PROPOFOL ? unclear Mechanistic
SAF312 inhibits Mechanistic
GRC-15300 ? unclear Mechanistic
AZD1386 inhibits Mechanistic
TIVANISIRAN inhibits Mechanistic
MAVATREP inhibits Mechanistic
MR-1817 inhibits Mechanistic
FERRUGINENE B ? unclear Mechanistic
CAPSAICIN activates Mechanistic 19.95 nM (EC50)
RECOMBINANT TUMOR NECROSIS FACTOR FAMILY PROTEIN ? unclear Mechanistic
PHENETHYLISOTHIOCYANATE ? unclear Mechanistic
VOACANGINE ? unclear Mechanistic
RESINIFERATOXIN activates Mechanistic 23.1 nM (Ki)
DWP05195 inhibits Mechanistic
XEN-D0501 inhibits Mechanistic
PAC-14028 inhibits Mechanistic
SB-705498 inhibits Mechanistic
MASOPROCOL ? unclear Mechanistic
ALLYL ISOTHIOCYANATE ? unclear Mechanistic
NGD-8243 inhibits Mechanistic
GRC-6211 inhibits Mechanistic
RESERPINE ? unclear Mechanistic
NABIXIMOLS ? unclear Mechanistic
A425619 ? unclear Mechanistic
PHE377 inhibits Mechanistic
ANTISENSE OLIGONUCLEOTIDES ? unclear Mechanistic
WORTMANNIN ? unclear Mechanistic
JTS-653 inhibits Mechanistic
LEVODOPA ? unclear Mechanistic
AMG517 inhibits Mechanistic
CAPSAZEPINE ? unclear Mechanistic 120.0 nM (Ki)
ZUCAPSAICIN activates Mechanistic
INDOMETHACIN ? unclear Mechanistic
CHEMBL:CHEMBL191534 ? unclear Mechanistic
ABT-102 inhibits Mechanistic
ISOPROPYL ISOTHIOCYANATE ? unclear Mechanistic

Showing top 40 of 160 agents ranked by evidence tier.


Clinical Trials

Recruiting and recently completed trials from ClinicalTrials.gov. Data retrieved 2026-07-06.

No recent clinical trials found on ClinicalTrials.gov for this condition.


Agents Found By Disease-Level Search

Searched directly from “Fibromyalgia” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 6-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).

Not yet run. python -m biomarker_pipeline.run_disease_agent_discovery --disease "..."

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation The OSMF hub — advancing open-source biomedical research infrastructure, tools, and evidence synthesis.
SpikeProtein.site Database and research resource on SARS-CoV-2 spike protein biology, persistence, and clinical implications.
Vaccine Data Navigator Open-access navigation tool for vaccine adverse event reporting and surveillance data.
PACVS Research Summit Annual summit convening researchers, clinicians, and patients on PACVS science.